ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,767.50
0.10%
S&P ASX All Technology
3,137.90
0.55%
Brent Oil
84.85
0.00%
US Dollar vs AUD
1.49566
0.00%
Bitcoin
60,965.16
1.08%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Bivictrix Therapeutics Plc (BVX) Share Price

Bivictrix Therapeutics Plc

Bivictrix Therapeutics Plc (BVX)

LSE
12.50
0.00
(0.00%)
Closed 29 June 1:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
12.50
Bid
12.00
Offer
13.00
Volume
0.00
12.50 Day's Range 12.50
10.00 52 Week Range 15.90
Market Cap
10.316M
Previous Close
12.50
Open
12.50
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
18,197
Shares Outstanding
82,526,088
Dividend Yield
-
PE Ratio
-4.06
Earnings Per Share (EPS)
-0.03
Revenue
-
Net Profit
-2.55M

About Bivictrix Therapeutics Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.bivictrix.com
Headquarters
Manchester, Gbr
Founded
1970
Bivictrix Therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker BVX. The last closing price for Bivictrix Therapeutics was 12.50p. Over the last year, Bivictrix Therapeutics shares have traded in a share price range of 10.00p to 15.90p.

Bivictrix Therapeutics currently has 82,526,088 shares in issue. The market capitalisation of Bivictrix Therapeutics is £10.32 million. Bivictrix Therapeutics has a price to earnings ratio (PE ratio) of -4.06.

BVX Latest News

More News

BiVictriX Therapeutics PLC Publication of 2023 Annual Report & Notice of AGM

BiVictriX Therapeutics PLC 26 June 2024     BIVICTRIX THERAPEUTICS PLC ("BiVictriX" or the "Company")   Publication of 2023 Annual Report and Notice of AGM   Alderley Park, 26 June 2024...

26 June 2024
RNS Regulatory News

EARNINGS AND TRADING: Dialight trades in line; Petards swings to loss

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

14 June 2024
Alliance News

BiVictriX Therapeutics PLC Compelling Safety Profile of BVX001

BiVictriX Therapeutics PLC 13 June 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH...

13 June 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Innovate UK Grant Award to Accelerate ADC Pipeline

BiVictriX Therapeutics PLC 06 June 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH...

06 June 2024
RNS Regulatory News

EARNINGS AND TRADING: CT UK High Income tops benchmark, ups dividend

The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not sepa ...

01 June 2024
Alliance News

BiVictriX Therapeutics PLC BiVictriX – Full Year Results 2023

BiVictriX Therapeutics PLC 31 May 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH...

31 May 2024
RNS Regulatory News

Bivictrix granted FDA orphan drug status for rare cancer treatment

Bivictrix Therapeutics PLC on Wednesday said its BVX001 drug has been granted special status by the US Food and Drug ...

17 April 2024
Alliance News

BiVictriX Therapeutics PLC Orphan Drug Designation & FDA INTERACT Meeting

BiVictriX Therapeutics PLC 17 April 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH...

17 April 2024
RNS Regulatory News
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10012.512.512.5258512.5DE
418.6956521739111.512.511.5745912.27449725DE
121.2511.111111111111.2512.5101819711.3342065DE
26219.047619047610.512.5105664610.84006596DE
52-2.5-16.66666666671515.9104280711.36654807DE
156-10-44.444444444422.533.5109280021.11533231DE
260-10-44.444444444422.533.5109280021.11533231DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LDROLode Resources Ltd
AUD 0.005
(400.00%)
49.26k
TKMOTrek Metals Limited
AUD 0.002
(100.00%)
277.78k
IBGOIronbark Zinc Limited
AUD 0.002
(100.00%)
1.25M
BFCBeston Global Food Company Limited
AUD 0.003
(50.00%)
8.94M
TD1Tali Digital Limited
AUD 0.0015
(50.00%)
1.05M
RAGORagnar Metals Limited
AUD 0.001
(-75.00%)
1M
ACMOAAustralian Critical Minerals Ltd
AUD 0.013
(-56.67%)
45k
AEVOAvenira Limited
AUD 0.001
(-50.00%)
3M
GRLOGodolphin Resources Limited
AUD 0.001
(-50.00%)
3M
HYTOHyTerra Ltd
AUD 0.011
(-35.29%)
1.2M
PENPeninsula Energy Ltd
AUD 0.1025
(0.00%)
77.12M
SYASayona Mining Limited
AUD 0.036
(-2.70%)
59.44M
ADNAndromeda Metals Limited
AUD 0.016
(-11.11%)
49.06M
IMUImugene Limited
AUD 0.057
(5.56%)
45.01M
SGRStar Entertainment Group Limited
AUD 0.50
(2.56%)
40.45M

Discussion

View Full Feed
Fiscall Fiscall 11 minutes ago
🚨 160k extra shares short! 🚨

🔥 They will all burn in hell! 🔥

📉 **Short Percent of Float:** 17.08%
📈 **Short % Increase:** +1%
🔢 **Current Short Interest:** 20,400,000
📊 **Shares Float:*
LWLG
arizona1 arizona1 13 minutes ago
So I clicked on the link and these guys are really funny.

https://x.com/i/status/1614068259732525060
moola26 moola26 14 minutes ago
Haha so true. With all the stocks out there they fixated on ours. Obviously paid agenda. Let them keep telling us how important and valuable our shares are.

MAJORITY HOLDING STRONG $$$$
Steady_T Steady_T 15 minutes ago
The P value combined with the sample size can indicate the strength of the effect. It will not reveal the absolute value. The smaller the n, the larger the effect must be to obtain a significant p (0.05) value. With a constant n, the smaller the p
AVXL
justhefax justhefax 15 minutes ago
Curious consideration -

They reported 3+ mm revs last qtr. That was w/o Kona hemp or cbd bevs contributing.

The forecast was for 12mm eoy. This likely assumed contributions from now delayed thc bev launch.

Lets say 10 mm revised. Note- they should update
KGKG
Tahoe2468 Tahoe2468 19 minutes ago
The company informed Nasdaq's hearing panel that it will target a post-reverse split stock price of at least $5 per share. The company also stated that if its stock price naturally reaches Nasdaq's minimum price requirement, it may postpone or not implement the reverse split.
FFIE
janice shell janice shell 21 minutes ago
Absolutely!! She’s now a progressive heroine. She’s great!
Karlchen Karlchen 22 minutes ago
QUOTE ........... "Absolutely nothing is 100%"

Ha, know what you mean . . but that's true for this sentence above too, lol

have an eyes weakend
NWBO
rbtree rbtree 22 minutes ago
Amateur hour. Explains this stinking pile quite clearly.
BMXI
arizona1 arizona1 23 minutes ago
LOLOL That was good. The male version of Sarah Cooper.
rbtree rbtree 25 minutes ago
What "press"? STAL stinks to high heaven...as do you..for you lying BS on the beer scam.
STAL
rikkie rikkie 26 minutes ago
Slim6 , absolutely NO guilt, no matter what you say!
LWLG
Scarbender307 Scarbender307 27 minutes ago
You guys are welcome...Go AOC!!
AOIFF
rbtree rbtree 28 minutes ago
Click bait nonsense. No shorting in this scam, ever. Deal with it.
KEGS
rikkie rikkie 29 minutes ago
Shorters clearly get more and more difficult. As soon as the share price rises, they start shorting en masse. This is clearly reflected in the graphs.
The buyers' shares will disappear from the scene, but the shorts' shares will have to be bought back en masse. What a glorious moment it will
LWLG
rbtree rbtree 30 minutes ago
Looks like the pump is fizzling.... Looks like less than a third of the trades went off above .0001..

In a couple days, .0002 will most likely be a distant memory.
KEGS
BDEZ BDEZ 31 minutes ago
Yup...
arizona1 arizona1 32 minutes ago
It's hard to believe Jennifer Rubin used to be such a staunch republican. Now, she's one of the best spokespeople we have.

Opinion | Jennifer Rubin: How I went from Republican to ...

What the debate told us: Biden’s facts are no match for Trump’s lies

T
Seminole Red Seminole Red 32 minutes ago
ready for the Revenuers ...
JamesLH JamesLH 34 minutes ago
So you also agree Campanella is a conman pretending to be a "CEO" of a company with one employee that's caused thousands of investors to lose millions right?

You agree even though he wasn't charged, the Department of Justice detailed how Campanella FORGED letters claiming he had 3M ma
SNPW
Seminole Red Seminole Red 35 minutes ago
relatives of the posters here....lol
janice shell janice shell 36 minutes ago
Why we need a woman in the Oval Office:

https://x.com/LeilaniDowding/status/1806707580246409357
Seminole Red Seminole Red 36 minutes ago
ck out the wheels on the truck....so cool

Your Recent History

LSE
BVX
Bivictrix Therapeutics
BIT
F12837
Vontobel Financial Produ...
LSE
105L
AQSE
PET.GB
Petrel Resources
KOSPI
005610
SPC Samlip
LSE
YF93
Citi Fun 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved